Edition:
India

St. Jude Medical Inc (STJ.N)

STJ.N on New York Stock Exchange

79.02USD
2 Dec 2016
Change (% chg)

$0.24 (+0.30%)
Prev Close
$78.78
Open
$78.95
Day's High
$79.25
Day's Low
$78.83
Volume
450,830
Avg. Vol
751,169
52-wk High
$84.00
52-wk Low
$48.83

STJ.N

Chart for STJ.N

About

St. Jude Medical, Inc. is focused on the development, manufacture and distribution of cardiovascular medical devices for the global cardiac rhythm management, cardiovascular and atrial fibrillation therapy areas, and interventional pain therapy and neurostimulation devices for the management of chronic pain and movement... (more)

Overall

Beta: 1.25
Market Cap(Mil.): $22,934.46
Shares Outstanding(Mil.): 285.72
Dividend: 0.31
Yield (%): 1.54

Financials

EU regulator conditionally approves Abbott's purchase of St Jude

BRUSSELS The European Commission on Wednesday said it has given its conditional approval to U.S. medical device maker Abbott Laboratories' bid for peer St Jude Medical Inc .

23 Nov 2016

EU regulator conditionally approves Abbott's purchase of St Jude

BRUSSELS, Nov 23 The European Commission on Wednesday said it has given its conditional approval to U.S. medical device maker Abbott Laboratories' bid for peer St Jude Medical Inc.

23 Nov 2016

New St. Jude heart pumping device proves superior to older model: study

NEW ORLEANS St. Jude Medical Inc's new, smaller HeartMate 3 heart pumping assist device proved superior to its older HeartMate II in advanced heart failure patients, according to the first data from a large trial presented on Wednesday.

16 Nov 2016

New St. Jude heart pumping device proves superior to older model -study

NEW ORLEANS, Nov 16 St. Jude Medical Inc's new, smaller HeartMate 3 heart pumping assist device proved superior to its older HeartMate II in advanced heart failure patients, according to the first data from a large trial presented on Wednesday.

16 Nov 2016

Exclusive - EU regulators seen clearing $25 billion Abbott, St Jude deal: source

EU antitrust regulators are expected to give conditional clearance to U.S. medical device maker Abbott Laboratories' $25 billion bid for rival St. Jude Medical Inc, a person familiar with the matter said on Tuesday.

16 Nov 2016

Exclusive: EU regulators seen clearing $25 billion Abbott, St Jude deal: source

EU antitrust regulators are expected to give conditional clearance to U.S. medical device maker Abbott Laboratories' $25 billion bid for rival St. Jude Medical Inc , a person familiar with the matter said on Tuesday.

16 Nov 2016

Deals of the day - Mergers and acquisitions

Nov 15 The following bids, mergers, acquisitions and disposals were reported by 2100 GMT on Tuesday:

16 Nov 2016

BRIEF-St. Jude Medical gains CE mark approval for MRI labeling of its Quadra Allure MP cardiac Resynchronization Therapy Pacemaker

* st. Jude medical gains CE mark approval for MRI labeling of its quadra allure mp cardiac resynchronization therapy pacemaker Source text for Eikon: Further company coverage:

07 Nov 2016

Abbott offers EU concessions over $25 billion St. Jude deal

BRUSSELS Medical device maker Abbott Laboratories has offered concessions in an attempt to secure EU antitrust approval for its $25 billion bid for St Jude Medical Inc , according to the European Commision.

03 Nov 2016

Abbott offers EU concessions over $25 bln St Jude deal

BRUSSELS, Nov 3 Medical device maker Abbott Laboratories has offered concessions in an attempt to secure EU antitrust approval for its $25 billion bid for St Jude Medical Inc, according to the European Commision.

03 Nov 2016

Earnings vs. Estimates